Taiwan's iXensor receives strategic investment to expand mobile health biz globally

Taiwan's iXensor, the pioneer of mobile health, has announced that Rohto Pharmaceutical Co., Ltd, a multinational pharma...

April 28, 2022 | Thursday | News
Orient EuroPharma gains rights to Contrave for Taiwan

Orient EuroPharma has signed a deal with the US branded and generic drugmaker Currax Pharmaceuticals to bring the weight...

April 6, 2022 | Wednesday | News
Taiwan accepts CANbridge's NDA for Alagille Syndrome

CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...

March 29, 2022 | Tuesday | News
Taiwan's Health2Sync partners with Novo Nordisk Pharma

Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate c...

March 28, 2022 | Monday | News
Lotus Pharma buys Cialis (Tadalafil) in Taiwan from Lilly for $57.5M

Lotus Pharmaceuticals has acquired trademark, marketing authorization, and manufacturing know-how of Tadalafil 2.5mg, 5m...

March 24, 2022 | Thursday | News
OBI Pharma enters license agreement with Odeon Therapeutics

OBI Pharma, Inc. (OBI), a Taiwan biopharma company, and Odeon Therapeutics (Odeon), a China biopharma company, have ente...

March 14, 2022 | Monday | News
SOPHiA GENETICS HRD Solution makes way in Asia Pacific

SOPHiA GENETICS has announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan aimi...

March 10, 2022 | Thursday | News
Taiwan approves Merck's KEYTRUDA in combination with Eisai's LENVIMA

Eisai Co., Ltd. announced that LENVIMA® (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase i...

March 9, 2022 | Wednesday | News
Taiwan-based firms to develop global CDMO for inhalation treatment drugs

Taiwan-based HCmed Innovations has formed a strategic alliance with Formosa Laboratories and Formosa Pharmaceuticals, In...

March 7, 2022 | Monday | News
Taiwan's ITRI to launch iPMx molecular rapid test system for COVID-19 in Japan

The iPMx Molecular Rapid Test System, developed by the Industrial Technology Research Institute (ITRI) in Taiwan, with t...

March 1, 2022 | Tuesday | News
Taiwan approves new first-line treatment for advanced renal cell carcinoma

Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...

January 31, 2022 | Monday | News
Lung cancer screening leading to over-diagnosis in Taiwan: Study

A new study based on data from a national cancer registry in Taiwan found evidence that lung cancer screening may be lea...

January 21, 2022 | Friday | News
H2U raises $8M to power new health ecosystem in Taiwan

Health to U (H2U) Corporation, an industry-leader in connected healthcare technology and provider of digital health and ...

January 18, 2022 | Tuesday | News
Eisai strengthens brain health assessment in Asia

Australian firm Cogstate, via its global commercial partner Eisai has announced that Cogstate technology will be markete...

January 14, 2022 | Friday | News
Taiwan's GoldenBiotech suggests 100% recovery with oral drug Antroquinonol in COVID-19 patients

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...

January 10, 2022 | Monday | News
MediBalloon establishes mass production capabilities in Taiwan

US-based MediBalloon, Inc. has announced a partnership with Medeon Biodesign, Inc., a Taiwan publicly traded m...

January 4, 2022 | Tuesday | News
Taiwan’s Acura NanoMedicine reduces drug resistance in cancer cells

Taiwanese startup Acura NanoMedicine Inc has announced a groundbreaking nanotech-based solution to reduce instances of d...

December 14, 2021 | Tuesday | News
Taiwanese firms strengthen CDMO investment and M&A plan

Taiwan-based Bora Pharmaceuticals has announced a partnership with Taishin Healthcare whereby the two parties will joint...

December 9, 2021 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls